Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.94B | 9.89B | 10.07B | 10.00B | 9.82B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.94B | 9.89B | 10.07B | 10.00B | 9.82B |
| Cost of Revenue | 2.51B | 2.48B | 2.57B | 2.65B | 2.66B |
| Gross Profit | 7.43B | 7.41B | 7.49B | 7.34B | 7.15B |
| SG&A Expenses | 2.47B | 2.43B | 2.43B | 2.41B | 2.38B |
| Depreciation & Amortization | 531.80M | 507.10M | 486.10M | 460.50M | 420.00M |
| Other Operating Expenses | 306.30M | 290.20M | 277.40M | 259.50M | 246.90M |
| Total Operating Expenses | 7.23B | 7.07B | 7.18B | 7.28B | 7.21B |
| Operating Income | 2.71B | 2.82B | 2.88B | 2.72B | 2.61B |
| Income Before Tax | 1.62B | 1.56B | 1.90B | 1.80B | 1.75B |
| Income Tax Expenses | 251.10M | 263.60M | 295.50M | 267.20M | 273.10M |
| Earnings from Continuing Operations | 1.37K | 1.29K | 1.61K | 1.53K | 1.48K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.37B | 1.29B | 1.61B | 1.53B | 1.48B |
| EBIT | 2.71B | 2.82B | 2.88B | 2.72B | 2.61B |
| EBITDA | 3.51B | 3.60B | 3.65B | 3.46B | 3.32B |
| EPS Basic | 9.35 | 8.83 | 10.99 | 10.48 | 10.15 |
| Normalized Basic EPS | 10.92 | 11.44 | 11.65 | 10.85 | 10.42 |
| EPS Diluted | 9.32 | 8.81 | 10.96 | 10.45 | 10.12 |
| Normalized Diluted EPS | 10.89 | 11.41 | 11.62 | 10.82 | 10.39 |
| Average Basic Shares Outstanding | 587.00M | 585.90M | 584.90M | 584.00M | 583.10M |
| Average Diluted Shares Outstanding | 588.90M | 587.10M | 586.50M | 585.50M | 584.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |